Center-Authored Papers

Filters: Author is Cecil, Denise L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Disis ML, Watt WC, Cecil DL.  2014.  Th1 epitope selection for clinically effective cancer vaccines.. Oncoimmunology. 3(9):e954971. Abstract
Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML.  2013.  T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.. Breast cancer research and treatment. 139(3):657-65. Abstract
S
Watt WC, Cecil DL, Disis ML.  2016.  Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.. Seminars in immunopathology. Abstract
P
Liao JB, Ovenell KJ, Curtis EEM, Cecil DL, Koehnlein MR, Rastetter LR, Gad EA, Disis ML.  2015.  Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer.. Journal for immunotherapy of cancer. 3:16. Abstract
M
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
I
Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.  2016.  Immunization against HIF-1α inhibits the growth of basal mammary tumors and targets mammary stem cells in vivo.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
E
Cecil DL, Holt GE, Park KH, Gad E, Rastetter L, Childs J, Higgins D, Disis ML.  2014.  Elimination of IL-10-Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity.. Cancer research. 74(10):2710-8. Abstract